Printer Friendly

ORTHOMET OBTAINS LICENSE FROM MAYO FOR FINGER JOINT REPLACEMENT PRODUCT

 MINNEAPOLIS, Jan. 7 /PRNewswire/ -- Orthomet, Inc. (NASDAQ: OMET) announced today that it has obtained an exclusive worldwide license from the Mayo Foundation for Medical Education and Research to manufacture and market an implantable prosthesis that replaces the proximal interphalangeal (PIP) or middle joint in fingers.
 Orthomet will pay a royalty to the Mayo Foundation based on sales of the product. It has successfully produced prototypes and currently is supplying devices on a custom order basis for use in ongoing clinical trials. An application to the Food and Drug Administration for approval to market the product is being prepared. Patients experiencing severe pain and loss of function in PIP joints due to degenerative diseases such as arthritis, and who have not responded to other forms of therapy, would be candidates for the implantable prosthesis.
 Richard D. Nikolaev, Orthomet's chairman and chief executive officer, said, "We are very pleased to be working with Mayo on this project. We actively pursue associations of this kind to augment our internal development efforts, since a constant flow of new products will be essential to setting Orthomet apart in the orthopaedic market and to achieving our goals."
 Orthomet, Inc. designs, manufactures and markets selected orthopaedic reconstructive implant products and related surgical instrumentation.
 -0- 1/7/93
 /CONTACT: James C. Hawley of Orthomet, 612-944-6112/
 (OMET)


CO: Orthomet, Inc. ST: Minnesota IN: MTC SU:

KH -- MN006 -- 2584 01/07/93 10:35 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 7, 1993
Words:235
Previous Article:BALLISTIVET RETAINS MANAGEMENT CONSULTING FIRM FOR TWO-YEAR FULL TIME CONTRACT; NAMES THREE PRINCIPALS TO KEY MANAGEMENT POSITIONS
Next Article:MYRIAD NEW PRODUCTS TO BE INTRODUCED AT WINDOWS & OS/2 CONFERENCE
Topics:


Related Articles
ORTHOMET, INC. RECEIVES FDA APPROVAL FOR EXTENSION TO KNEE PRODUCT LINE; BEGINS TRIAL DISTRIBUTION IN U.S. OF 3M SHOULDER PRODUCT
ORTHOMET NAMES HAWLEY EXECUTIVE VICE PRESIDENT; ANNOUNCES FDA HAS APPROVED IMPORTANT KNEE IMPLANT PRODUCT FOR MARKETING
ORTHOMET RECEIVES FDA APPROVAL TO MARKET NEW HIP PRODUCTS
ORTHOMET OBTAINS ADDITIONAL LICENSES FROM MAYO FOR FINGER JOINT REPLACEMENT PRODUCTS
ORTHOMET ENTERS FIVE-YEAR AGREEMENT TO DISTRIBUTE 3M RECONSTRUCTIVE SHOULDER PRODUCTS
FDA GRANTS ORTHOMET APPROVAL TO MARKET IMPORTANT ADDITIONS TO ITS KNEE PRODUCT LINE
ORTHOMET AND KIRSCHNER SIGN LETTER OF INTENT TO MERGE
ORTHOMET ANNOUNCES MERGER AGREEMENT WITH WRIGHT
WRIGHT MEDICAL TECHNOLOGY SUCCESSFULLY COMPLETES TENDER OFFER FOR ALL OUTSTANDING COMMON AND 6% CONVERTIBLE PREFERRED STOCK OF ORTHOMET
WRIGHT MEDICAL TECHNOLOGY SUCCESSFULLY COMPLETES TENDER OFFER FOR ALL OUTSTANDING COMMON AND 6% CONVERTIBLE PREFERRED STOCK OF ORTHOMET

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters